No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Optiscan Imaging Limited specializes in the development and market introduction of confocal microscopy technology, applied across both clinical and pre-clinical settings in Australia, Germany, and other global regions. A notable offering is the FIVE2 (ViewnVivo) system, a compact confocal endomicroscope utilized for a broad range of research, including clinical, translational, and pre-clinical studies. Additionally, the company is actively developing the InVivage device, which is intended for use in cancer screening and surgical procedures. Established in 1994, Optiscan Imaging Limited maintains its headquarters in Mulgrave, Australia.
www.optiscan.comNo one on the platform currently holds OIL.AX.
No tracked institution reports a position in OIL.AX as of their last filing.
No one on the platform has traded OIL.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| OIL.AXOptiscan Imaging Limited | $0.14 | -9.38% | $151M | — |
| AXE.AXArcher Materials Limited | $0.19 | +2.70% | $53M | — |
| DCC.AXDigitalX Limited | $0.03 | +0.00% | $45M | — |
| DVL.AXdorsaVi Ltd | $0.02 | +0.00% | $30M | — |
| EIQ.AXEcho IQ Limited | $0.54 | +11.34% | $399M | — |
| IOD.AXIODM Limited | $0.09 | -2.08% | $60M | — |
| NVU.AXNanoveu Limited | $0.06 | -2.50% | $64M | — |
Source: Financial Modeling Prep · peers by sector/industry